Document is current
Any future updates will be listed below
-
Authors
McCallum, Matthew https://orcid.org/0000-0001-8398-8330
Case, James Brett https://orcid.org/0000-0001-7331-5511
Brown, Jack T.
Park, Young-Jun https://orcid.org/0000-0003-2901-6949
Lee, Jimin
Sutherland, Emmajay https://orcid.org/0000-0001-5150-4346
Aggarwal, Anupriya
Gibson, Cecily
Lempp, Florian A. https://orcid.org/0000-0001-6103-8078
Stewart, Cameron https://orcid.org/0000-0002-2786-6256
Tortorici, M. Alejandra https://orcid.org/0000-0002-2260-2577
Sanapala, Shilpa
Low, Jun Siong
Asarnow, Daniel https://orcid.org/0000-0001-7870-5308
Bohan, Dana https://orcid.org/0000-0002-9239-3053
Dellota, Exequiel Jr.
Merz, Benjamin
Chawla, Bhavna
Kar, Swagata
Lanzavecchia, Antonio https://orcid.org/0000-0002-3041-7240
Sallusto, Federica
Riley, Nicholas M. https://orcid.org/0000-0002-1536-2966
Turville, Stuart
Purcell, Lisa
Diamond, Michael S. https://orcid.org/0000-0002-8791-3165
Veesler, David https://orcid.org/0000-0002-6019-8675
- License Information
-
More Information
Article History
Received: 19 February 2026
Accepted: 31 March 2026
First Online: 28 April 2026
Competing interests
: L.A.P. is named as an inventor on patent applications describing the H1H7 antibody and on patents and patent applications for TMPRSS function and models. L.A.P. is a former employee and shareholder of Vir Biotechnology and Regeneron Pharmaceuticals and is an advisor to the AI-driven structure-enabled antiviral platform (ASAP). F.A.L., E.D. and D.B. are current or former employees of Vir Biotechnology and may hold shares in the company. M.M. and D.V. are named on patent applications filed by the University of Washington describing stabilized E-FIC constructs. M.S.D. is a consultant or advisor for Inbios, Vir Biotechnology, IntegerBio, Akagera Medicines and GlaxoSmithKline. The M.S.D. laboratory has received unrelated funding support in sponsored research agreements from Emergent BioSolutions, Generate Biomedicines and Moderna. The other authors declare no competing interests.
